Literature DB >> 17063225

Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder.

Chei Tung Teng, Frederico Navas Demetrio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17063225     DOI： 10.1590/s1516-44462006000300020

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN： 1516-4446            Impact factor:   2.697


× No keyword cloud information.
  16 in total

1.  Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder.

Authors:  Epolia Ramadan; Mireille Basselin; Jagadeesh S Rao; Lisa Chang; Mei Chen; Kaizong Ma; Stanley I Rapoport
Journal:  Int J Neuropsychopharmacol       Date:  2011-06-28       Impact factor: 5.176

Review 2.  Predictive animal models of mania: hits, misses and future directions.

Authors:  Jared W Young; Brook L Henry; Mark A Geyer
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

3.  Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.

Authors:  Katherine E Burdick; Raphael J Braga; Charles U Nnadi; Yaniv Shaya; Walter H Stearns; Anil K Malhotra
Journal:  J Clin Psychiatry       Date:  2011-11-29       Impact factor: 4.384

Review 4.  The management of cognitive impairment in bipolar disorder: current status and perspectives.

Authors:  Marsal Sanches; Isabelle E Bauer; Juan F Galvez; Giovana B Zunta-Soares; Jair C Soares
Journal:  Am J Ther       Date:  2015 Nov-Dec       Impact factor: 2.688

Review 5.  New drugs for bipolar disorder.

Authors:  Marsal Sanches; Jair C Soares
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

Review 6.  Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Lobna A Ibrahim; Nancy Diaz-Granados; Carlos A Zarate
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 7.  Bipolar disorder: candidate drug targets.

Authors:  Carlos A Zarate; Husseini K Manji
Journal:  Mt Sinai J Med       Date:  2008 May-Jun

Review 8.  Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy.

Authors:  Katherine E Burdick; Raphael J Braga; Joseph F Goldberg; Anil K Malhotra
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 9.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.

Authors:  Gerard Sanacora; Carlos A Zarate; John H Krystal; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

10.  Memantine in the management of a clinically challenging case of bipolar disorder.

Authors:  Vivek Agarwal; Adarsh Tripathi
Journal:  Indian J Psychiatry       Date:  2009-04       Impact factor: 1.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.